TYKERB

Welcome to the Brand page for “TYKERB”, which is offered here for In the statement, column 1, line 7 through column 2, line 3, infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and skin and tissue repair preparations is deleted.;pharmaceutical preparations for the treatment of cancer[, infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and skin and tissue repair preparations];.

Its status is currently believed to be active. Its class is unavailable. “TYKERB” is believed to be currently owned by “NOVARTIS PHARMA AG”.


Owner:
NOVARTIS PHARMA AG
Owner Details
Description:
In the statement, Column 1, line 7 through Column 2, line 3, INFECTIOUS DISEASES, PAIN, INFLAMMATION, SEPSIS, ALOPECIA AND OBESITY, AND FOR THE TREATMENT OF METABOLIC, MUSCULOSKELETAL, CARDIOVASCULAR, CARDIOPULMONARY, GENITOURINARY, RESPIRATORY, NEUROLOGICAL, GASTROINTESTINAL, HORMONAL, DERMATOLOGICAL AND PSYCHIATRIC RELATED DISEASES AND DISORDERS AND SKIN AND TISSUE REPAIR PREPARATIONS is deleted.;Pharmaceutical preparations for the treatment of cancer[, infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and skin and tissue repair preparations];
Categories: STATEMENT